OncoCyte Corporation

NasdaqCM:OCX 株式レポート

時価総額：US$50.5m

OncoCyte マネジメント

マネジメント 基準チェック /24

OncoCyte's CEO is Josh Riggs, appointed in Dec 2022, has a tenure of 1.92 years. total yearly compensation is $724.91K, comprised of 46.9% salary and 53.1% bonuses, including company stock and options. directly owns 0.021% of the company’s shares, worth $10.52K. The average tenure of the management team and the board of directors is 1.7 years and 3.8 years respectively.

主要情報

Josh Riggs

最高経営責任者

US$724.9k

報酬総額

CEO給与比率46.9%
CEO在任期間1.9yrs
CEOの所有権0.02%
経営陣の平均在職期間1.7yrs
取締役会の平均在任期間3.8yrs

経営陣の近況

Recent updates

Is OncoCyte (NASDAQ:OCX) In A Good Position To Invest In Growth?

Oct 28
Is OncoCyte (NASDAQ:OCX) In A Good Position To Invest In Growth?

Oncocyte stock jumps ~15% after hours on contract for lung-cancer detection test

Aug 30

Revisiting OncoCyte Corp.

May 04

Is OncoCyte (NASDAQ:OCX) Using Debt Sensibly?

Jan 25
Is OncoCyte (NASDAQ:OCX) Using Debt Sensibly?

OncoCyte signs an at-the-market agreement to sell $50M of common stock

Jun 14

Despite Lacking Profits OncoCyte (NASDAQ:OCX) Seems To Be On Top Of Its Debt

Jun 02
Despite Lacking Profits OncoCyte (NASDAQ:OCX) Seems To Be On Top Of Its Debt

CEO報酬分析

OncoCyte の収益と比較して、Josh Riggs の報酬はどのように変化したか？
日付総報酬給与会社業績
Jun 30 2024n/an/a

-US$37m

Mar 31 2024n/an/a

-US$40m

Dec 31 2023US$725kUS$340k

-US$26m

Sep 30 2023n/an/a

-US$22m

Jun 30 2023n/an/a

-US$17m

Mar 31 2023n/an/a

-US$11m

Dec 31 2022US$514kUS$242k

-US$19m

報酬と市場: Josh's total compensation ($USD724.91K) is about average for companies of similar size in the US market ($USD655.65K).

報酬と収益: Josh's compensation has increased whilst the company is unprofitable.

CEO（最高経営責任者

Josh Riggs (41 yo)

1.9yrs

在職期間

US$724,910

報酬

Mr. Joshua Riggs, also known as Josh, serves as Director of OncoCyte Corporation since February 28, 2023, serves as its Chief Executive Officer & President since February 24, 2023. He served as Interim Chi...

リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Joshua Riggs
President1.9yrsUS$724.91k0.021%
$ 10.5k
James Liu
Senior Director2.2yrsUS$304.51k0%
$ 0
Ekkehard Schutz
Chief Science Officer1.8yrsUS$575.17k0.030%
$ 15.3k
Andrea James
Chief Financial Officerless than a yearデータなし0.20%
$ 101.0k
Yuh-Min Chiang
Chief Technology Officer1.5yrsデータなしデータなし
Peter Hong
VP, General Counsel & Secretaryless than a yearデータなしデータなし
Sandra O'Donald
Senior Vice President of Business Operations1.3yrsデータなしデータなし
Michael West
Scientific Advisor9.1yrsUS$328.84kデータなし

1.7yrs

平均在職期間

41yo

平均年齢

経験豊富な経営陣: OCX's management team is not considered experienced ( 1.7 years average tenure), which suggests a new team.

取締役

名称ポジション在職期間報酬所有権
Joshua Riggs
President1.8yrsUS$724.91k0.021%
$ 10.5k
Louis Silverman
Lead Independent Director2yrsUS$97.70k0.0093%
$ 4.7k
Andrew Arno
Independent Chairman9.4yrsUS$112.54k0.50%
$ 254.0k
Daniel Hayes
Member of Scientific & Medical Advisory Board3.8yrsデータなしデータなし
David R. Gandara
Member of Scientific & Medical Advisory Boardno dataデータなしデータなし
Robert Ferris
Member of Scientific & Medical Advisory Boardno dataデータなしデータなし
John Kirkwood
Member of Scientific & Medical Advisory Board3.8yrsデータなしデータなし
Andrew Last
Independent Director8.9yrsUS$92.86k0.027%
$ 13.5k
Fred Hirsch
Member of Scientific & Medical Advisory Board3.8yrsデータなしデータなし
Heinz-Josef Lenz
Member of Scientific & Medical Advisory Board3.8yrsデータなしデータなし
Ignacio Wistuba
Member of Scientific & Medical Advisory Board3.8yrsデータなしデータなし

3.8yrs

平均在職期間

64.5yo

平均年齢

経験豊富なボード: OCX's board of directors are considered experienced (3.8 years average tenure).